Description

Neocarazostatin C CAS NO 137714-93-3 is a specialized bioactive compound belonging to the class of ansamycin antibiotics, known for its potent inhibitory properties. This high-purity compound is critical for advanced research and development in life sciences, offering a reliable reference standard for pharmacological studies. It is primarily utilized by pharmaceutical R&D teams, academic researchers, and biotechnology companies focused on discovering novel therapeutic agents and studying microbial resistance mechanisms.

Application

• Pharmaceutical Research & Development: Serves as a key reference standard and active pharmaceutical ingredient (API) intermediate in the discovery of new antibiotic and anticancer agents.
• Biochemical Mechanism Studies: Used to investigate the mode of action of ansamycins and their interactions with biological targets such as heat shock protein 90 (Hsp90).
• Microbiology & Antimicrobial Research: Employed in studies focusing on novel pathways to combat drug-resistant bacterial strains and fungal infections.
• Academic & Institutional Research: Provides a high-purity compound for university laboratories and research institutes conducting fundamental studies in natural product chemistry and biosynthesis.
• Biotechnology Applications: Utilized in cell-based assays and high-throughput screening (HTS) platforms to identify and validate new drug candidates.
• Quality Control & Analytical Standards: Acts as a certified reference material (CRM) for the calibration of analytical instruments like HPLC and LC-MS in quality assurance laboratories.

Basic Information

Product Name	Neocarazostatin C
CAS No.	137714-93-3
Molecular Formula	C32H43NO9
Molecular Weight	585.69 g/mol
Synonyms	Neocarazostatin C; Antibiotic C 14919; C-14919; Ansamycin C-14919; Benzenepropanamide, N-[(1S,2E,4E,8S,9S,10E,12S,13R)-8,13-dihydroxy-1,2,10-trimethyl-6-oxo-3,16-dioxabicyclo[10.3.1]hexadeca-2,4,10,14-tetraen-9-yl]-4-hydroxy-3,5-dimethoxy-; (8S,9S,12S,13R)-Neocarazostatin C
EINECS	Contact for details

Quality Control

Every batch of Neocarazostatin C is manufactured and analyzed under strict quality management systems to ensure identity, purity, and consistency. Our products undergo rigorous quality testing, including advanced chromatographic and spectroscopic methods, to ensure compliance with research-grade standards. A comprehensive Certificate of Analysis (COA), detailing purity, assay results, and impurity profiles, is provided with each shipment and is available upon request.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. The product is hygroscopic (moisture-sensitive) and should be handled under anhydrous conditions to maintain potency. Allow the vial to equilibrate to room temperature in a desiccator before opening to prevent condensation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Assay	≥ 97.0% (on anhydrous basis)
Water Content (KF)	≤ 3.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.